The purpose of this contract is to acquire genome characterization center (GCC) services consisting of large-scale, high- resolution, and comprehensive sequencing and array platforms. The sequencing…
Active Awarded Last action
- Contract number
- 75N91025D00006
- Awardee
-
New York Genome Center, Inc. UEI WKPTJDWG2C68
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- NCI Genomic Characterization Centers Pre-Solicitation · 75N91024R00001 · Posted Dec 6, 2022
- Last date to order 36% complete
- IDV ceiling
- $149,173,285.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 11 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute awarded a multiple-award Indefinite Delivery Contract to New York Genome Center, Inc. for Genome Characterization Center (GCC) services with a ceiling of $149,173,285 and an award date of January 13, 2025.
The contract funds large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing and related genomic characterization capabilities. Place of performance is at the awardee's New York, New York headquarters. The period of performance runs through January 12, 2030.
The originating solicitation, posted December 6, 2022 with a due date of January 4, 2023, sought genomic characterization center services to support the National Cancer Institute's research mission. This is one of multiple awards under the NCI Genomic Characterization Centers program. The contract carries no set-aside designation and reflects a full-and-open procurement.
Description
The purpose of this contract is to acquire genome characterization center (GCC) services consisting of large-scale, high- resolution, and comprehensive sequencing and array platforms. The sequencing and array platforms include whole exome sequencing
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91025D00006?
75N91025D00006 was awarded to New York Genome Center, Inc. by National Cancer Institute (National Institutes of Health) on January 13, 2025.
How much is contract 75N91025D00006 worth?
75N91025D00006's own ceiling is $149,173,285.
Who can order from contract 75N91025D00006?
75N91025D00006 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N91025D00006 part of a contract vehicle?
Yes. 75N91025D00006 is part of NCI Genomic Characterization Centers.
Was contract 75N91025D00006 competed?
The extent of competition for 75N91025D00006 was full and open competition. The government received 11 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV